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vii. Main text 
Background  
Pre-clinical evidence has shown all common anesthetic drugs are toxic to the developing brain1.  
Despite numerous cohort studies and one randomised control trial (RCT)2, it remains unclear 
whether anesthetic-induced neurotoxicity exists and if intraoperative physiological disturbance 
plays a role. Well-designed RCTs with long-term follow-up are required to examine this. Infants 
requiring repair of oral cleft may provide an optimal clinical model; they often undergo multiple 
surgeries and have routine, nationally agreed, long-term speech and language assessments 
which extend into early adulthood. We aimed to describe anesthetic technique for repair of oral 
cleft in a pediatric tertiary referral hospital, and assess intraoperative physiological disturbance to 
inform design of a future RCT.  
Methods 
We performed an anonymised retrospective case review of all infants undergoing repair of oral 
cleft during a 12month period; ethical approval was not required. Data were collected on 
anesthetic duration, perioperative drugs administered and intra-operative physiology. Age-
adjusted MAC (minimum alveolar concentration) was calculated by dividing the end-tidal volatile 
concentration by the age-specific MAC3. Hypotension was defined using mean arterial pressure 
(MAP) into mild (MAP:36-45mmHg), moderate (MAP:26-35mmHg), and severe 
(MAP≤25mmHg)4. Normocarbia was defined as EtCO2 between 4.0-6.0kPa.  
Results  
38 infants underwent 53 surgeries to repair an oral cleft. Mean (SD) age: 6.9months (2.56), mean 
(SD) weight: 7.21kg (1.53). 15 infants had two surgeries, 28 surgeries (53.8%) were completed 
before 6months of age. 79% of infants had an isolated cleft with no other comorbidities.  
Median (IQR) duration of anesthesia was 90mins (75-122.5); duration ranged from 45-180mins 
but only one case lasted under 60mins. Median (IQR) cumulative duration for the infants 




Volatile anesthetics were used for induction and maintenance of anesthesia in all cases. Mean 
(SD) age-adjusted MAC for isoflurane, sevoflurane and desflurane was: 0.70 (0.113), 0.88 (0.099) 
and 0.79 (0.066), respectively. Isoflurane was used in 73.5% of cases, sevoflurane in 20.7%. Five 
cases maintained with concomitant nitrous oxide had an isoflurane mean (SD) age-adjusted MAC 
of 0.51 (0.088); all these infants were under 6 months of age. 
Mean (SD) FiO2 was 0.52 (0.134) with 46% of data points documented as FiO2 ≥0.5. Mean (SD) 
EtCO2 was within normal limits at 5.26kPa (0.736) but ranged from 3.2-8.0kPa. Hypocarbia was 
recorded 10 times in 10 cases (18.9%); hypercarbia was recorded 46 times in 21 cases (39.6%). 
Hypotension occurred in 23 (45%) cases: 20 mild, 3 moderate (see figure). All infants received 
intra-operative fluid, mean (SD) volume: 20.4ml/kg (6.64). No infants received vasopressors. 
At induction: a muscle relaxant was used in 50 cases (atracurium 48, rocuronium 2), fentanyl in 
50 cases, alfentanil in one. Surgical field infiltration of 0.25% bupivacaine occurred in 48 cases 
(90.6%). Intra-operative IV analgesia consisted of fentanyl (69.8%), morphine (15.1%) tramadol 
(15.1%), oxycodone (15.1%) and diclofenac (13.2%). 
Discussion  
Infants undergoing oral cleft repair in our centre have high cumulative exposure to volatile 
anesthesia and commonly experience physiological homeostatic disturbances during these 
elective surgical procedures. Reducing or replacing these agents with drugs such as xenon or 
dexmedetomidine could potentially decrease the risk of anesthetic-induced neurotoxicity by the 
dual mechanism of decreasing exposure of the developing brain to neurotoxic agents, and 
reducing intraoperative physiological derangement5. Further reduction of anesthetic volatiles may 
be facilitated by the addition of opioids or intravenous lignocaine. 
Regional blockade and sedation may be all that is required to provide optimal surgical conditions, 
the addition of volatile anesthetics may represent a relative overdose. Local anesthetic was used 
in most cases in our study and this may explain how a low mean age-adjusted MAC could be 





Most babies born with cleft lip and/or palate undergo corrective surgery during infancy. They are 
commonly exposed to prolonged, repeated, anesthesia in the first year of life. Intraoperative 
physiological control is often deranged.  With long-term neurological assessment part of their 
routine care, this elective surgical population may be an optimal model to investigate anesthetic-
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x. Figure legends 
Figure: Scatterplot of MAP versus time for each volatile. Hypotension: (mild <45mmHg; moderate 
<35mmHg; severe <25mmHg) 
